相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The β-Secretase BACE1 in Alzheimer's Disease
Harald Hampel et al.
BIOLOGICAL PSYCHIATRY (2021)
Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials
Angela Tian Hui Kwan et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2021)
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease A Truncated Randomized Phase 2b/3 Clinical Trial
Reisa Sperling et al.
JAMA NEUROLOGY (2021)
Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brain
Audrey Valverde et al.
ACTA NEUROPATHOLOGICA (2021)
The crystal structure of a 250-kDa heterotetrameric particle explains inhibition of sheddase meprin ß by endogenous fetuin-B
Ulrich Eckhard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Phosphorylation of meprin β controls its cell surface abundance and subsequently diminishes ectodomain shedding
Fred Armbrust et al.
FASEB JOURNAL (2021)
Alzheimer's disease: the controversial approval of Aducanumab
Fabrizio Tagliavini et al.
NEUROLOGICAL SCIENCES (2021)
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Nour M. Moussa-Pacha et al.
MEDICINAL RESEARCH REVIEWS (2020)
AP-2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons
Sujoy Bera et al.
EMBO REPORTS (2020)
Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
Gerald Novak et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders
Vivian Hook et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
APP Family Regulates Neuronal Excitability and Synaptic Plasticity but Not Neuronal Survival
Sang Hun Lee et al.
NEURON (2020)
Current and Future Treatments in Alzheimer Disease: An Update
Konstantina G. Yiannopoulou et al.
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2020)
A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment
Brati Das et al.
CNS DRUGS (2019)
Tethering soluble meprin α in an enzyme complex to the cell surface affects IBD-associated genes
Florian Peters et al.
FASEB JOURNAL (2019)
Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases
Konstantin Karmilin et al.
SCIENTIFIC REPORTS (2019)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression
Filip Liebsch et al.
NATURE COMMUNICATIONS (2019)
Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage
Rielana Wichert et al.
FASEB JOURNAL (2019)
The metalloprotease ADAMTS4 generates N-truncated A4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease
Susanne Walter et al.
ACTA NEUROPATHOLOGICA (2019)
A cellular complex of BACE1 and γ-secretase sequentially generates Aβ from its full-length precursor
Lei Liu et al.
JOURNAL OF CELL BIOLOGY (2019)
BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
Xiangyou Hu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
Wilbur M. Song et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease
T. Patel et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Amyloid toxicity in Alzheimer's disease
Allison B. Reiss et al.
REVIEWS IN THE NEUROSCIENCES (2018)
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
Joseph W. Arndt et al.
SCIENTIFIC REPORTS (2018)
The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease
Ulf Neumann et al.
EMBO MOLECULAR MEDICINE (2018)
Dipeptidyl-Peptidase Activity of Meprin β Links N-truncation of Aβ with Glutaminyl Cyclase-Catalyzed pGlu-Aβ Formation
Dagmar Schlenzig et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease
Gvido Cebers et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology
Patrick Gavin Kehoe et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Mouse Models of Alzheimer's Disease
Gisela Esquerda-Canals et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid A Peptides
Kei Sakamoto et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system
Lucas J. Sosa et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Practical considerations for choosing a mouse model of Alzheimer's disease
Joanna L. Jankowsky et al.
MOLECULAR NEURODEGENERATION (2017)
Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1
Miao Sun et al.
NEUROBIOLOGY OF AGING (2017)
Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients
Claire Bridel et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Meprin metalloproteases: Molecular regulation and function in inflammation and fibrosis
Philipp Arnold et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway
Utpal Das et al.
NATURE NEUROSCIENCE (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence
Ayano Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site
Caroline Schoenherr et al.
MOLECULAR NEURODEGENERATION (2016)
Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
Martina Pigoni et al.
MOLECULAR NEURODEGENERATION (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Matthew E. Kennedy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Metalloprotease meprin β is activated by transmembrane serine protease matriptase-2 at the cell surface thereby enhancing APP shedding
Felix Jaeckle et al.
BIOCHEMICAL JOURNAL (2015)
Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer's Transgenic Mice Lessen During Disease Progression
Latha Devi et al.
CURRENT ALZHEIMER RESEARCH (2015)
Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level
Katherine R. Sadleir et al.
MOLECULAR NEURODEGENERATION (2015)
APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice
De-shan Liu et al.
MOLECULAR NEURODEGENERATION (2015)
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family
Richard Kelwick et al.
GENOME BIOLOGY (2015)
Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease
Bernhard Clemens Richard et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
Martina Sattlecker et al.
ALZHEIMERS & DEMENTIA (2014)
Brain Pyroglutamate Amyloid-beta is Produced by Cathepsin B and is Reduced by the Cysteine Protease Inhibitor E64d, Representing a Potential Alzheimer's Disease Therapeutic
Gregory Hook et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2014)
The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin beta and ADAM10
Tamara Jefferson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Expression and function of APP and its metabolites outside the central nervous system
Kendra L. Puig et al.
EXPERIMENTAL GERONTOLOGY (2013)
Intracellular Itinerary of Internalised β-Secretase, BACE1, and Its Potential Impact on β-Amyloid Peptide Biogenesis
Pei Zhi Cheryl Chia et al.
TRAFFIC (2013)
Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
Sang-Sun Yoon et al.
BIOMOLECULES & THERAPEUTICS (2012)
Early-Onset Familial Alzheimer's Disease (EOFAD)
Liyong Wu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2012)
Deletion of the Cathepsin B Gene Improves Memory Deficits in a Transgenic Alzheimer's Disease Mouse Model Expressing A beta PP Containing the Wild-Type beta-Secretase Site Sequence
Mark S. Kindy et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The Metalloprotease Meprin β Generates Amino Terminal-truncated Amyloid β Peptide Species
Jessica Bien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System
Niklas Mattsson et al.
PLOS ONE (2012)
Trafficking and Proteolytic Processing of APP
Christian Haass et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells
Silke Brunholz et al.
EXPERIMENTAL BRAIN RESEARCH (2012)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
Plasma Fetuin-A is Associated with the Severity of Cognitive Impairment in Mild-to-Moderate Alzheimer's Disease
Edward R. Smith et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
A Window into the Heterogeneity of Human Cerebrospinal Fluid Aβ Peptides
Roberta Ghidoni et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Proteomic Analyses Reveal an Acidic Prime Side Specificity for the Astacin Metalloprotease Family Reflected by Physiological Substrates
Christoph Becker-Pauly et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
APP processing in Alzheimer's disease
Yun-Wu Zhang et al.
MOLECULAR BRAIN (2011)
Fetuin-A and Cystatin C Are Endogenous Inhibitors of Human Meprin Metalloproteases
Jana Hedrich et al.
BIOCHEMISTRY (2010)
Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation
Anke Ohler et al.
BIOLOGICAL CHEMISTRY (2010)
Structural Design, Solid-Phase Synthesis and Activity of Membrane-Anchored beta-Secretase Inhibitors on A beta Generation from Wild-Type and Swedish-Mutant APP
Heinke Schieb et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2010)
Processing of Procollagen III by Meprins: New Players in Extracellular Matrix Assembly?
Daniel Kronenberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Meprin A and meprin α generate biologically functional IL-1β from pro-IL-1β
Christian Herzog et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease
Clifford R. Jack et al.
BRAIN (2009)
Aminopeptidase A contributes to the N-terminal truncation of amyloid β-peptide
Jean Sevalle et al.
JOURNAL OF NEUROCHEMISTRY (2009)
APP Anterograde Transport Requires Rab3A GTPase Activity for Assembly of the Transport Vesicle
Anita Szodorai et al.
JOURNAL OF NEUROSCIENCE (2009)
The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential
Robert Vassar et al.
JOURNAL OF NEUROSCIENCE (2009)
A guide to the Proteomics Identifications Database proteomics data repository
Juan Antonio Vizcaino et al.
PROTEOMICS (2009)
Prointerleukin-18 Is Activated by Meprin β in Vitro and in Vivo in Intestinal Inflammation
Sanjita Banerjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inhibitors of cathepsin B improve memory and reduce β-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, β-secretase site of the amyloid precursor protein
Vivian Y. H. Hook et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons
Jenny M. Gunnersen et al.
NEURON (2007)
A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1
Claudio Costantini et al.
BIOCHEMICAL JOURNAL (2007)
The α and β subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiation
Christoph Becker-Pauly et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
GGA1 is expressed in the human brain and affects the generation of amyloid β-peptide
Tina Wahle et al.
JOURNAL OF NEUROSCIENCE (2006)
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice
Kouhei Nishitomi et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Bace1 modulates myelination in the central and peripheral nervous system
Xiangyou Hu et al.
NATURE NEUROSCIENCE (2006)
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain
A. Guentert et al.
NEUROSCIENCE (2006)
GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing
Christine A. F. von Arnim et al.
JOURNAL OF NEUROSCIENCE (2006)
Extracellular release of BACE1 holoproteins from human neuronal cells
KS Murayama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions
FM Laird et al.
JOURNAL OF NEUROSCIENCE (2005)
GGA proteins mediate the recycling pathway of memapsin 2 (BACE)
XY He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease
M Ohno et al.
NEURON (2004)
Human BACE forms dimers and colocalizes with APP
A Schmechel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Amino-truncated amyloid β-peptide (Aβ5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain
K Takeda et al.
FASEB JOURNAL (2004)
Dimerization of β-site β-amyloid precursor protein-cleaving enzyme
GG Westmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Demonstration of BACE (β-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy
CAF von Arnim et al.
JOURNAL OF CELL SCIENCE (2004)
In vivo inhibition of Aβ production by memapsin 2 (β-secretase) inhibitors
WP Chang et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Phorbol 12-myristate 13-acetate-induced ectodomain shedding and phosphorylation of the human meprinβ metalloprotease
D Hahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
M Puchades et al.
MOLECULAR BRAIN RESEARCH (2003)
Characterization of the ectodomain shedding of the β-site amyloid precursor protein-cleaving enzyme 1 (BACE1)
I Hussain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes
A Kinoshita et al.
JOURNAL OF CELL SCIENCE (2003)
Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase
M Asai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
β-Secretase (BACE) as a drug target for alzheimer's disease
R Vassar
ADVANCED DRUG DELIVERY REVIEWS (2002)
β-secretase protein and activity are increased in the neocortex in Alzheimer disease
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2002)
Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2002)
β-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain
JT Huse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Glul1 site cleavage and N-terminally truncated Aβ production upon BACE overexpression
KN Liu et al.
BIOCHEMISTRY (2002)
The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total Aβ
L Pastorino et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activity
F Fischer et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Elevation of β-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells
J Wiltfang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Early formation of mature amyloid-β protein deposits in a mutant APP transgenic model depends on levels of Aβ1-42
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Characterization of the glycosylation profiles of Alzheimer's β-secretase protein Asp-2 expressed in a variety of cell lines
J Charlwood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphorylation regulates intracellular trafficking of β-secretase
J Walter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The Pro domain of β-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain
XP Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
Y Luo et al.
NATURE NEUROSCIENCE (2001)
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
HB Cai et al.
NATURE NEUROSCIENCE (2001)
Processing of β-secretase by furin and other members of the proprotein convertase family
JWM Creemers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's β-secretase
BD Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Maturation and pro-peptide cleavage of β-secretase
A Capell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Amyloid β protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain
Y Harigaya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Characterization of Alzheimer's β-secretase protein BACE -: A pepsin family member with unusual properties
M Haniu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
